164 related articles for article (PubMed ID: 38216991)
1. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S
Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991
[TBL] [Abstract][Full Text] [Related]
2. High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.
Sugino H; Satomi K; Mori T; Mukai Y; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Yoshida A
Brain Tumor Pathol; 2023 Apr; 40(2):133-141. PubMed ID: 36811792
[TBL] [Abstract][Full Text] [Related]
3. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
[TBL] [Abstract][Full Text] [Related]
4. Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.
Yamazaki A; Arai Y; Fukuoka K; Nakano Y; Hama N; Nakata S; Makino K; Kuroda JI; Shinojima N; Mukasa A; Mikami Y; Ichimura K; Shibata T; Yokoo H; Nobusawa S
Brain Tumor Pathol; 2022 Jul; 39(3):171-178. PubMed ID: 35596897
[TBL] [Abstract][Full Text] [Related]
5. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
Tauziède-Espariat A; Uro-Coste E; Sievers P; Nicaise Y; Mariet C; Siegfried A; Pierron G; Guillemot D; Benzakoun J; Pallud J; Roques M; Bonneville F; Larrieu-Ciron D; Chaynes P; Saffroy R; Hamelin J; Hasty L; Métais A; Chrétien F; Kool M; Gojo J; Varlet P;
Acta Neuropathol Commun; 2023 Feb; 11(1):26. PubMed ID: 36782314
[TBL] [Abstract][Full Text] [Related]
6. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
[TBL] [Abstract][Full Text] [Related]
7. Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.
Pisapia DJ; Ohara K; Bareja R; Wilkes DC; Hissong E; Croyle JA; Kim JH; Saab J; MacDonald TY; Beg S; O'Reilly C; Kudman S; Rubin MA; Elemento O; Sboner A; Greenfield J; Mosquera JM
Acta Neuropathol Commun; 2020 Jun; 8(1):80. PubMed ID: 32493417
[TBL] [Abstract][Full Text] [Related]
8. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
[TBL] [Abstract][Full Text] [Related]
9. CNS tumor with BCOR internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors.
Wang R; Guan W; Qiao M; Zhang Y; Zhang M; Wang K; Wang Y; Wang L
Pathol Res Pract; 2022 Aug; 236():153995. PubMed ID: 35809497
[TBL] [Abstract][Full Text] [Related]
10. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.
Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR
Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276
[TBL] [Abstract][Full Text] [Related]
11. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
[TBL] [Abstract][Full Text] [Related]
12. BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets.
Nakata S; Yuan M; Rubens JA; Kahlert UD; Maciaczyk J; Raabe EH; Eberhart CG
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920124
[TBL] [Abstract][Full Text] [Related]
13. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
[TBL] [Abstract][Full Text] [Related]
14. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not OLIG2.
Salgado CM; Zin A; Garrido M; Kletskaya I; DeVito R; Reyes-Múgica M; Bisogno G; Donofrio V; Alaggio R
Pediatr Dev Pathol; 2020; 23(6):424-430. PubMed ID: 32790583
[TBL] [Abstract][Full Text] [Related]
16. Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.
Kao YC; Sung YS; Zhang L; Huang SC; Argani P; Chung CT; Graf NS; Wright DC; Kellie SJ; Agaram NP; Ludwig K; Zin A; Alaggio R; Antonescu CR
Am J Surg Pathol; 2016 Aug; 40(8):1009-20. PubMed ID: 26945340
[TBL] [Abstract][Full Text] [Related]
17. BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.
Kao YC; Sung YS; Zhang L; Jungbluth AA; Huang SC; Argani P; Agaram NP; Zin A; Alaggio R; Antonescu CR
Am J Surg Pathol; 2016 Dec; 40(12):1670-1678. PubMed ID: 27428733
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
[TBL] [Abstract][Full Text] [Related]
19. BCOR involvement in cancer.
Astolfi A; Fiore M; Melchionda F; Indio V; Bertuccio SN; Pession A
Epigenomics; 2019 May; 11(7):835-855. PubMed ID: 31150281
[No Abstract] [Full Text] [Related]
20. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.
Appay R; Macagno N; Padovani L; Korshunov A; Kool M; André N; Scavarda D; Pietsch T; Figarella-Branger D
Am J Surg Pathol; 2017 Sep; 41(9):1254-1260. PubMed ID: 28704208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
